The past few years have seen growing recognition of the need for patient-centric drug delivery devices that support effective administration of new biologic medications. This has inspired significant investment in this area by global pharma players.
As a result, the pharma industry is increasingly turning to wearable drug delivery devices as the preferred method for bringing new medications to market. This has placed the burden of responsibility on device manufacturers to respond with robust and reliable devices that are also easy-to-use and able to support digital connectivity.
One important question that a pharmaceutical company has to raise when it intends to use an on-body delivery systems (OBDS) is: Can a combination drug product be marketed with a pre-filled, pre-loaded solution that doesn’t require changes to the primary container already used or existing fill/ finish processes established by the pharmaceutical partner?
In this webinar you will learn that the answer can be “yes”.
In the first part of the presentation, you will get an insight into the options of OBDS devices. A brief comparison of a variety of systems will provide a better understanding of problems faced when looking for the best solution for the delivery of a large molecule. We will tell you what it means to the patient to open, swab, and insert the primary container into a device without error compared to using a ´ready- to-use´, 'peel-and-stick' patient centric device.
Finally we will explain how the LTS Sorrel Platform can help pharma partners to leverage their existing primary container systems and fill/ finish processes and to stay true to their ambition of never, ever, compromising on the science they trust while better meeting patient needs.
Key Learning Objectives
- What is an OBDS and what can it be used for?
- What is the ideal wearable solution for pharma partners and what are current solutions?
- How does the LTS Sorrel Platform allow Pharma Companies to provide a convenient, easy to use device to patients without the need to change existing primary container systems or fill/ finish processes
